Results 1 to 10 of about 68,509 (152)

Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy [PDF]

BMC Cancer, 2019
Background Budding is a complementary prognostic factor for colorectal cancer. In this study, we aimed to clarify the role of tumor budding in rectal cancer patients after preoperative chemoradiotherapy. Methods A total of 124 patients with rectal cancer
Iryna Trotsyuk, Halina Sparschuh, Alice Josephine Müller, Konrad Neumann, Martin Kruschewski, David Horst, Sefer Elezkurtaj   +6 more
doaj   +3 more sources

Pathological and Clinical Significance of Tumor Budding and Its Association with Epithelial-Mesenchymal Transition in Colorectal Carcinoma: A Retrospective Observational Study [PDF]

Iranian Journal of Medical Sciences
Background: Metastases, not the primary tumor, account for most cancer-related deaths. Tumor budding, thought to represent epithelial-mesenchymal transition (EMT), has garnered attention due to its association with invasion and migration. This study aims
Bashar Al Hassawi
doaj   +2 more sources

Tumor budding in invasive breast carcinoma and its association with clinicopathological parameters: an experience from a tertiary care center in India [PDF]

Korean Journal of Clinical Oncology
Purpose Breast cancer is one of the most common cancers globally, with an increasing incidence rate. It is a heterogeneous disease, and early metastasis remains a challenge.
Asmita Shah, Shaivy Malik, Adil Aziz Khan, Charanjeet Ahluwalia   +3 more
doaj   +2 more sources

Associations of Biomarkers of Systemic Inflammation, Angiogenesis, and Cell‐to‐Cell Adhesion With Tumor Budding Among Early‐Onset and Later‐Onset Colorectal Cancer Patients [PDF]

Cancer Medicine
Background High tumor budding and elevated systemic inflammation are adverse prognostic indicators in colorectal cancer. Its underlying mechanisms remain poorly understood.
Oda Hausmann, Pauline P. Schobert, Jennifer Ose, Caroline Himbert, Maria Pletneva, Jolanta Jedrzkiewicz, Anne Nguyen, Tengda Lin, Christy A. Warby, Sheetal Hardikar, Anita R. Peoples, Ildiko Strehli, Lyen C. Huang, Jessica N. Cohan, Bartley Pickron, Courtney Scaife, Christopher I. Li, William M. Grady, David Shibata, Adetunji T. Toriola, Martin Schneider, Jane C. Figueiredo, Erin M. Siegel, Biljana Gigic, Stephan Herzig, Mmadili N. Ilozumba, Cornelia M. Ulrich   +26 more
doaj   +2 more sources

Correlation Between Tumor Budding and Survivin Expression in Colorectal Cancer [PDF]

Clinical and Experimental Gastroenterology
Guangping Zhang, Qingzhong Min Department of Pathology, Ya’an People’s Hospital, Ya’an, Sichuan, People’s Republic of ChinaCorrespondence: Qingzhong Min, Department of Pathology, Ya’an People’s Hospital, Ya’an, Sichuan, People’s Republic of China, Tel ...
Zhang G, Min Q
doaj   +2 more sources

Combined Model of Tumor–Stroma Ratio and Tumor Budding Are Not Associated with Tumor Recurrence or Metastasis in Oral Squamous Cell Carcinoma Patients [PDF]

Diagnostics
Histopathological grading of oral squamous cell carcinoma is currently based on differentiation of cells, while additional histological parameters, such as the tumor–stroma ratio (TSR), tumor budding (TB), or the combined TSR/tumor budding model could ...
Drago Boščić, Emili Dragaš, Andro Košec, Goran Geber, Čedna Tomasović-Lončarić, Davor Vagić   +5 more
doaj   +2 more sources

Tumor Budding as an Independent Prognostic Histopathological Marker in Oral Squamous Cell Carcinoma - An Indian Tertiary Care Center Experience [PDF]

Türk Patoloji Dergisi
Objective: Oral squamous cell carcinoma is the most common head and neck malignancy reported worldwide. Tumor budding represents a histopathological feature characterized by the presence of isolated single/small clusters of cancer cells dispersed within ...
Anand Vijaya NARAYANAN, Krishnapriya UMASHANKAR, Sithara ARAVIND, Sangeetha. K. NAYANAR, Sandeep VIJAY   +4 more
doaj   +2 more sources

Tumor budding - a potential biomarker in low grade salivary gland carcinomas? [PDF]

Frontiers in Oncology
BackgroundLow-grade salivary gland carcinoma is regularly treated with surgical therapy of the salivary gland without elective neck dissection in T1/2 carcinomas, either alone or with adjuvant radiation therapy.
Valentin Burkhardt, Gian Kayser, Theo Villing, Christoph Becker   +3 more
doaj   +2 more sources

The relationship between tumor budding and survival of patients with breast cancer: A meta-analysis [PDF]

Biomolecules & Biomedicine
Tumor budding has been proposed as a potential prognostic marker in various cancers, but its association with survival outcomes in breast cancer (BC) remains unclear.
Hongjie Xu, Dajun Wei
doaj   +2 more sources

Tumor budding in tumor tissue among operatively treated patients with lung adenocarcinoma [PDF]

Vojnosanitetski Pregled, 2021
Background/Aim. The histological phenomenon of tumor budding is being recognized as an important determinant of disease progression and poor prognosis in various types of carcinoma.
Vasilijević Milena, Lovrenski Aleksandra, Panjković Milana   +2 more
doaj   +1 more source